Articles

What do implants, vaccines, allergenic extracts, dialysis and ophthalmic solutions have in common? Sterility.

The International Society for Pharmaceutical Engineering (ISPE) released the term 'Advanced Aseptic Processing (AAP)', which covers both the Restricted Access Barrier System (RABS) and the isolators, which aims to cater for product protection and containment during on-going manufacturing operations by separating operators from the process.

The new medicinal technology, radionanomedicine, is the simultaneous application of nuclear medicine with nanomedicine. This takes advantage of radiomedicine using trace technology, where minute amounts of materials are biologically distributed in vivo.

Biosafety is defined as the discipline which addresses the containment and safe handling of infectious microorganisms and hazardous biological materials.

Last June 2017, the United States Food and Drug Administration (FDA) have released Draft Guidance regarding Product Identifier Requirements under the Drug Supply Chain Security Act (DSCSA).

Esco Healthcare unveils the first issue of its quarterly newsletter, The Health Quarters (The HQ), featuring its esteemed project highlight, informative behind-the-product technological principles and know-hows, as well as its latest innovative product advancements.

Esco Pharma USA commissioned a filling line isolator and open restricted access barrier system (oRABS) for a pharmaceutical manufacturing company in the USA.

Find out and get the latest updates on Technology and Solutions for Vaccine Manufacturing and Cell Culture from Esco Healthcare’s 2nd issue of its Quarterly Newsletter.